• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Incorporation of a Proteotyping Approach using Mass Spectrometry for the Surveillance of the Influenza Virus in Cell Cultured Strains

tetano

Editor, Senior Moderator
J Clin Microbiol. 2013 Nov 13. [Epub ahead of print]
Incorporation of a Proteotyping Approach using Mass Spectrometry for the Surveillance of the Influenza Virus in Cell Cultured Strains.
Fernandes ND, Downard KM.
Source

School of Molecular Bioscience, University of Sydney, Sydney, Australia.
Abstract

The reemergence of deadly pandemic influenza virus strains has necessitated the development of improved methods for the rapid detection and subtyping of influenza viruses that will enable more strains to be characterized at the molecular level. Representative circulating strains of human influenza viruses from primary clinical specimens were grown in cell culture, purified through polyethylene glycol precipitation, proteolytically digested with an endoproteinase, and analysed and identified by high resolution mass spectrometry using unique signature peptides that are characteristic of type A H1N1, H3N2 and type B influenza viruses. This proteotyping approach enabled circulating strains of type A influenza virus to be typed and subtyped, co-circulating seasonal and pandemic H1N1 viruses to be differentiated and the lineage of type B viruses to be determined through single ion detection by high resolution mass spectrometry. Results were obtained using virus titres comparable to those used in RT-PCR from clinical specimens grown in cell culture. The methodology represents a more rapid and direct approach over RT-PCR that can be integrated into existing procedures currently used for the surveillance of emerging pandemic and seasonal influenza viruses.

PMID:
24226917
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24226917
 
Back
Top Bottom